Preparation of alginate beads for floating drug delivery system: effects of CO(2) gas-forming agents.

Floating beads were prepared from a sodium alginate solution containing CaCO(3) or NaHCO(3) as gas-forming agents. The solution was dropped to 1% CaCl(2) solution containing 10% acetic acid for CO(2) gas and gel formation. The effects of gas-forming agents on bead size and floating properties were investigated. As gas-forming agents increased, the size and floating properties increased. Bead porosity and volume average pore size, as well as the surface and cross-sectional morphology of the beads were examined with Mercury porosimetry and Scanning Electron Microscopy. NaHCO(3) significantly increased porosity and pore diameter than CaCO(3). Incorporation of CaCO(3) into alginate solution resulted in smoother beads than those produced with NaHCO(3). Gel strength analysis indicated that bead strength decreased with increasing gas-forming agent from 9 to 4 N. Beads incorporating CaCO(3) exhibited significantly increased gel strength over control and NaHCO(3)-containing samples. Release characteristics of riboflavin as a model drug were studied in vitro. Release rate of riboflavin increased proportionally with addition of NaHCO(3). However, increasing weight ratios of CaCO(3) did not appreciably accelerate drug release. The results of these studies indicate that CaCO(3) is superior to NaHCO(3) as a gas forming agent in alginate bead preparations. The enhanced buoyancy and sustained release properties of CaCO(3)-containing beads make them an excellent candidate for floating drug dosage systems (FDDS).

[1]  A. Jayakrishnan,et al.  Oral Sustained‐release Drug Delivery Systems using Polycarbonate Microspheres Capable of Floating on the Gastric Fluid , 1993, The Journal of pharmacy and pharmacology.

[2]  P. Maincent,et al.  Evaluation of peroral silicone dosage forms in humans by gamma-scintigraphy. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[3]  J. Fell,et al.  Amoxycillin release from a floating dosage form based on alginates. , 2000, International journal of pharmaceutics.

[4]  P. Peiris,et al.  Encapsulation of probiotic bacteria with alginate-starch and evaluation of survival in simulated gastrointestinal conditions and in yoghurt. , 2000, International journal of food microbiology.

[5]  V. Pillay,et al.  Evaluation and comparison of dissolution data derived from different modified release dosage forms: an alternative method. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[6]  Kinam Park,et al.  Synthesis of fast-swelling, superporous sucrose hydrogels. , 2000 .

[7]  T. Desai,et al.  Bioadhesive microspheres: III. An in vivo transit and bioavailability study of drug-loaded alginate and poly(fumaric-co-sebacic anhydride) microspheres , 1997 .

[8]  E. Doelker,et al.  Drug absorption sites in the gastrointestinal tract and dosage forms for site-specific delivery , 1996 .

[9]  F. Forni,et al.  Effect of matrix composition and process conditions on casein-gelatin beads floating properties. , 2000, International journal of pharmaceutics.

[10]  Y. Kawashima,et al.  Hollow microspheres for use as a floating controlled drug delivery system in the stomach. , 1992, Journal of pharmaceutical sciences.

[11]  J. Timmermans,et al.  Factors controlling the buoyancy and gastric retention capabilities of floating matrix capsules: new data for reconsidering the controversy. , 1994, Journal of pharmaceutical sciences.

[12]  V. Yang,et al.  Controlled release of clot-dissolving tissue-type plasminogen activator from a poly(L-glutamic acid) semi-interpenetrating polymer network hydrogel. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[13]  C. J. Gray,et al.  Retention of insulin in alginate gel beads. , 1988, Biotechnology and bioengineering.

[14]  Sanford Bolton,et al.  A Floating Controlled-Release Drug Delivery System: In Vitro-in Vivo Evaluation , 1993, Pharmaceutical Research.

[15]  Gilberto Coppi,et al.  AIR COMPARTMENT MULTIPLE – UNIT SYSTEM FOR PROLONGED GASTRIC RESIDENCE (PART I. FORMULATION STUDY) , 1998 .

[16]  Mandel Kg,et al.  Review article : Alginate-raft formulations in the treatment of heartburn and acid reflux , 2000 .

[17]  D. Poncelet,et al.  A PHYSICO-CHEMICAL APPROACH TO PRODUCTION OF ALGINATE BEADS BY EMULSIFICATION-INTERNAL IONOTROPIC GELATION , 1999 .

[18]  E. Morris,et al.  Biological interactions between polysaccharides and divalent cations: The egg‐box model , 1973 .

[19]  J. Patočka,et al.  Some enzymatic properties of human brain acetylcholinesterase , 1969, FEBS letters.

[20]  P. Ma,et al.  Ionically crosslinked alginate hydrogels as scaffolds for tissue engineering: part 1. Structure, gelation rate and mechanical properties. , 2001, Biomaterials.

[21]  Y. Murata,et al.  Use of floating alginate gel beads for stomach-specific drug delivery. , 2000, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[22]  Brahma N. Singh,et al.  Floating drug delivery systems: an approach to oral controlled drug delivery via gastric retention. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[23]  C. Rhodes,et al.  Development of a Novel Controlled-Release System for Gastric Retention , 1997, Pharmaceutical Research.

[24]  J. Azuma,et al.  Evaluation of Oral Mucoadhesive Microspheres in Man on the Basis of the Pharmacokinetics of Furosemide and Riboflavin, Compounds with Limited Gastrointestinal Absorption Sites , 1998, The Journal of pharmacy and pharmacology.

[25]  S. Gronowitz,et al.  The Effect of Divalent Metals on the Properties of Alginate Solutions. I. Calcium Ions. , 1965 .

[26]  J Kristl,et al.  Optimisation of floating matrix tablets and evaluation of their gastric residence time. , 2000, International journal of pharmaceutics.

[27]  A. Badwan,et al.  A Sustained Release Drug Delivery System Using Calcium Alginate Beads , 1985 .

[28]  L. Balant,et al.  Comparative pharmacokinetic study of a floating multiple-unit capsule, a high-density multiple-unit capsule and an immediate-release tablet containing 25 mg atenolol. , 1998, Pharmaceutica acta Helvetiae.

[29]  S. Ochi,et al.  Sustained release liquid preparation using sodium alginate for eradication of Helicobacter pyroli. , 1999, Biological & pharmaceutical bulletin.

[30]  A. El-Kamel,et al.  Preparation and evaluation of ketoprofen floating oral delivery system. , 2001, International journal of pharmaceutics.

[31]  Masaki Ichikawa,et al.  A new multiple-unit oral floating dosage system. I: Preparation and in vitro evaluation of floating and sustained-release characteristics. , 1991, Journal of pharmaceutical sciences.

[32]  D. Craig,et al.  The effects of alginate molecular structure and formulation variables on the physical characteristics of alginate raft systems , 1997 .

[33]  J. Fell,et al.  Production and characterisation of enteric beads , 1995 .